XML 36 R25.htm IDEA: XBRL DOCUMENT
v3.21.2

Derivative Financial Instruments (Tables) | 9 Months Ended
--- | ---
Oct. 03, 2021
Derivative Instruments And Hedging Activities Disclosure [Abstract] |
Schedule of Fair Values of the Company's Derivative Instruments and the Line Items on the Unaudited Condensed Consolidated Balance Sheets | The fair values of the Company's derivative instruments and the line items on the unaudited condensed consolidated balance sheets to which they were recorded as of October 3, 2021, and December 31, 2020, were summarized as follows:
|  | Balance Sheet |  |  |  |  |  |  |  |  |  | Balance Sheet |  |  |  |  |  |  |  |
|  | Location |  | October 3, 2021 |  |  | December 31, 2020 |  |  | Location |  | October 3, 2021 |  |  | December 31, 2020 |
|  |  |  | (In thousands) |  |  |  |  | (In thousands) |
Derivatives not designated as hedging instruments |  | Prepaid expenses and other current assets |  | $ | 1,011 |  |  | $ | 324 |  |  | Other accrued liabilities |  | $ | 116 |  |  | $ | 2,344 |
Derivatives designated as hedging instruments |  | Prepaid expenses and other current assets |  |  | 5 |  |  |  | — |  |  | Other accrued liabilities |  |  | 1 |  |  |  | 38 |
Total |  |  |  | $ | 1,016 |  |  | $ | 324 |  |  |  |  | $ | 117 |  |  | $ | 2,382 |
Schedule of Company's Derivative Instruments on Accumulated Other Comprehensive Income and the Unaudited Condensed Consolidated Statement of Operations | The effects of the Company's derivative instruments on AOCI and the unaudited condensed consolidated statements of operations for the three and nine months ended October 3, 2021 and September 27, 2020 were summarized as follows:
|  | Three Months Ended |  |  | Nine Months Ended |
|  | October 3, 2021 |  |  | September 27, 2020 |  |  | October 3, 2021 |  |  | September 27, 2020 |
Derivatives designated as hedging instruments: |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Cash flow hedges |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Foreign currency forward contracts: |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Gains (losses) recognized in accumulated other comprehensive income - Effective Portion |  | $ | 444 |  |  | $ | (1,530 | ) |  | $ | (235 | ) |  | $ | (608 | )
Gains (losses) reclassified from accumulated other comprehensive income into income - Effective Portion (1): |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Net revenue |  | $ | 545 |  |  | $ | (1,614 | ) |  | $ | (407 | ) |  | $ | (595 | )
Cost of revenue |  | $ | (1 | ) |  | $ | 3 |  |  | $ | — |  |  | $ | 2 |
Research and development |  | $ | 12 |  |  | $ | 27 |  |  | $ | 56 |  |  | $ | 32 |
Sales and marketing |  | $ | (27 | ) |  | $ | 167 |  |  | $ | 50 |  |  | $ | 95 |
General and administrative |  | $ | (4 | ) |  | $ | 24 |  |  | $ | 13 |  |  | $ | 10 |
Derivatives not designated as hedging instruments: |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Gains (losses) recognized in Other income (expense), net |  | $ | 1,818 |  |  | $ | (1,424 | ) |  | $ | 2,871 |  |  | $ | (774 | )
(1) | Refer to Note 9, Stockholders' Equity, which summarizes the accumulated other comprehensive income activity related to derivatives.

X
- References No definition available. + Details
Name: | us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of gain (loss) on derivative and nonderivative instruments designated and qualifying as cash flow hedge recorded in accumulated other comprehensive income (AOCI) and reclassified into earnings. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 815 -SubTopic 10 -Section 50 -Paragraph 4C -Subparagraph (c) -URI http://asc.fasb.org/extlink&oid=125515794&loc=SL5624171-113959 + Details
Name: | us-gaap_ScheduleOfCashFlowHedgesIncludedInAccumulatedOtherComprehensiveIncomeLossTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of the location and fair value amounts of derivative instruments (and nonderivative instruments that are designated and qualify as hedging instruments) reported in the statement of financial position. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 815 -SubTopic 10 -Section 50 -Paragraph 4B -URI http://asc.fasb.org/extlink&oid=125515794&loc=SL5624163-113959 + Details
Name: | us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration